Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome
- 31 December 2004
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 177 (2) , 367-373
- https://doi.org/10.1016/j.atherosclerosis.2004.07.019
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patientsAtherosclerosis, 2003
- Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention StudyCirculation, 2003
- NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and OlderDiabetes, 2003
- History of Hypertension and Enhanced Thrombogenic Activity in Postinfarction PatientsHypertension, 2003
- Insulin resistance and the metabolic syndrome—a challenge of the new millenniumEuropean Journal of Clinical Nutrition, 2002
- Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes MellitusAnnals of Internal Medicine, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Thrombogenic Factors and Recurrent Coronary EventsCirculation, 1999
- Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in MenCirculation, 1997
- Principal component analysis and exploratory factor analysisStatistical Methods in Medical Research, 1992